Thermo Fisher Scientific

Thermo Fisher Scientific (TMO) is currently trading at $491.46. The stock has a 52-week range of $389.23 to $638.82 and a market capitalization of $182.57B.

Thermo Fisher Scientific has a P/E ratio of 27.7 (forward P/E: 18.3), a dividend yield of 0.36%, and 1-year performance of +4.9%. 15 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.

There have been 90 insider transactions for TMO in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.

Thermo Fisher Scientific (TMO) has returned +4.9% over the past 12 months. The stock traded between $389.23 and $638.82 during this period, and is currently at $491.46.

15 tracked hedge funds currently hold TMO in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.

Thermo Fisher Scientific (TMO) has a market capitalization of $182.57B. The trailing P/E ratio is 27.7 and forward P/E is 18.3. The stock is classified in the Healthcare sector.

Thermo Fisher Scientific reported revenue of $44.56B with net income of $6.70B and a profit margin of 0.15%. The stock has a beta of 0.97.

Thermo Fisher Scientific (TMO) operates in the Healthcare sector. It is held by 15 tracked hedge funds. See the ownership table above for the complete list.